Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 DNA methylation: its role in cancer development and therapy.

Literature DB >> 18926282

DNA methylation: its role in cancer development and therapy.

Carla Kurkjian¹, Shivaani Kummar, Anthony J Murgo.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2008 PMID： 18926282 PMCID： PMC2588419 DOI： 10.1016/j.currproblcancer.2008.08.002

Source DB: PubMed Journal: Curr Probl Cancer ISSN： 0147-0272 Impact factor: 3.187

× No keyword cloud information.

241 in total

1. Studies on the mechanism of the synergistic interaction between 2'-deoxy-5-azacytidine and cisplatin.

Authors: J L Abbruzzese; P Frost
Journal: Cancer Chemother Pharmacol Date: 1992 Impact factor: 3.333

Review 2. DNA methylation and gene silencing in cancer.

Authors: Stephen B Baylin
Journal: Nat Clin Pract Oncol Date: 2005-12

3. Combined DNA methyltransferase and histone deacetylase inhibition in the treatment of myeloid neoplasms.

Authors: Steven D Gore; Stephen Baylin; Elizabeth Sugar; Hetty Carraway; Carole B Miller; Michael Carducci; Michael Grever; Oliver Galm; Tianna Dauses; Judith E Karp; Michelle A Rudek; Ming Zhao; B Douglas Smith; Jasper Manning; Anchalee Jiemjit; George Dover; Abbie Mays; James Zwiebel; Anthony Murgo; Li-Jun Weng; James G Herman
Journal: Cancer Res Date: 2006-06-15 Impact factor: 12.701

4. Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells.

Authors: M Göttlicher; S Minucci; P Zhu; O H Krämer; A Schimpf; S Giavara; J P Sleeman; F Lo Coco; C Nervi; P G Pelicci; T Heinzel
Journal: EMBO J Date: 2001-12-17 Impact factor: 11.598

5. Further analysis of trials with azacitidine in patients with myelodysplastic syndrome: studies 8421, 8921, and 9221 by the Cancer and Leukemia Group B.

Authors: Lewis R Silverman; David R McKenzie; Bercedis L Peterson; James F Holland; Jay T Backstrom; C L Beach; Richard A Larson
Journal: J Clin Oncol Date: 2006-08-20 Impact factor: 44.544

6. Long-term follow-up of a phase I study of high-dose decitabine, busulfan, and cyclophosphamide plus allogeneic transplantation for the treatment of patients with leukemias.

Authors: Marcos de Lima; Farhad Ravandi; Munir Shahjahan; Borje Andersson; Daniel Couriel; Michele Donato; Issa Khouri; James Gajewski; Koen van Besien; Richard Champlin; Sergio Giralt; Hagop Kantarjian
Journal: Cancer Date: 2003-03-01 Impact factor: 6.860

7. Phase II study of low-dose decitabine in combination with imatinib mesylate in patients with accelerated or myeloid blastic phase of chronic myelogenous leukemia.

Authors: Yasuhiro Oki; Hagop M Kantarjian; Vazganush Gharibyan; Dan Jones; Susan O'brien; Srdan Verstovsek; Jorge Cortes; Gail M Morris; Guillermo Garcia-Manero; Jean-Pierre J Issa
Journal: Cancer Date: 2007-03-01 Impact factor: 6.860

8. Alterations of the p16(INK4) locus in human malignant mesothelial tumors.

Authors: Tomoko Hirao; Raphael Bueno; Chang-Jie Chen; Gavin J Gordon; Elizabeth Heilig; Karl T Kelsey
Journal: Carcinogenesis Date: 2002-07 Impact factor: 4.944

9. Hypermethylation of the p15INK4B gene promoter in B-chronic lymphocytic leukemia.

Authors: Sotirios G Papageorgiou; Stefanos Lambropoulos; Vassiliki Pappa; Christina Economopoulou; Frinta Kontsioti; Efstathios Papageorgiou; Panagiotis Tsirigotis; John Dervenoulas; Theofanis Economopoulos
Journal: Am J Hematol Date: 2007-09 Impact factor: 10.047

10. A survey of the humoral immune response of cancer patients to a panel of human tumor antigens.

Authors: E Stockert; E Jäger; Y T Chen; M J Scanlan; I Gout; J Karbach; M Arand; A Knuth; L J Old
Journal: J Exp Med Date: 1998-04-20 Impact factor: 14.307

24 in total

Review 1. DNA methylation and microRNAs in cancer.

Authors: Xiang-Quan Li; Yuan-Yuan Guo; Wei De
Journal: World J Gastroenterol Date: 2012-03-07 Impact factor: 5.742

2. Antineoplastic effects of decitabine, an inhibitor of DNA promoter methylation, in adrenocortical carcinoma cells.

Authors: Insoo Suh; Julie Weng; Gustavo Fernandez-Ranvier; Wen T Shen; Quan-Yang Duh; Orlo H Clark; Electron Kebebew
Journal: Arch Surg Date: 2010-03

Review 3. Therapeutic Targeting of Epithelial Plasticity Programs: Focus on the Epithelial-Mesenchymal Transition.

Authors: Reem Malek; Hailun Wang; Kekoa Taparra; Phuoc T Tran
Journal: Cells Tissues Organs Date: 2017-02-20 Impact factor: 2.481

Review 4. Coordinated chromatin control: structural and functional linkage of DNA and histone methylation.

Authors: Xiaodong Cheng; Robert M Blumenthal
Journal: Biochemistry Date: 2010-04-13 Impact factor: 3.162

Review 5. Regulation of estrogen receptor beta activity and implications in health and disease.

Authors: Elin Swedenborg; Krista A Power; Wen Cai; Ingemar Pongratz; Joëlle Rüegg
Journal: Cell Mol Life Sci Date: 2009-12 Impact factor: 9.261

6. A phase 1 and pharmacodynamic study of decitabine in combination with carboplatin in patients with recurrent, platinum-resistant, epithelial ovarian cancer.

Authors: Fang Fang; Curt Balch; Jeanne Schilder; Timothy Breen; Shu Zhang; Changyu Shen; Lang Li; Carol Kulesavage; Anthony J Snyder; Kenneth P Nephew; Daniela E Matei
Journal: Cancer Date: 2010-09-01 Impact factor: 6.860